The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Self-citationCalcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Self-citationTargan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Lichtiger, S., Present, D. H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., & Hanauer, S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302601 · Cited by 1,714
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
REGIONAL ILEITIS: A PATHOLOGIC AND CLINICAL ENTITY
CROHN, B. B. (1932) · Journal of the American Medical Association · doi:10.1001/jama.1932.02740680019005 · Cited by 1,512
Biological effects of cyclosporin A: A new antilymphocytic agent
Borel, J. F., Feurer, C., Gubler, H. U., & Stähelin, H. (1976) · Agents and Actions · doi:10.1007/bf01973261 · Cited by 1,509
National Cooperative Crohn's Disease Study: Results of drug treatment
Summers, R. W., Switz, D. M., Sessions, J. T., Becktel, J. M., Best, W. R., Kern, F., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90385-8 · Cited by 1,239
Cancer risk in patients with inflammatory bowel disease: A population-based study
Bernstein, C. N., Blanchard, J. F., Kliewer, E., & Wajda, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z · Cited by 1,165
Faubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26279 · Cited by 1,144
Järnerot, G., Hertervig, E., Friis-Liby, I., Blomquist, L., Karlén, P., Grännö, C., Vilien, M., Ström, M., Danielsson, Å., Verbaan, H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.003 · Cited by 1,089
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Rutgeerts, P., D'Haens, G., Targan, S., Vasiliauskas, E., Hanauer, S. B., Present, D. H., Mayer, L., Van Hogezand, R. A., Braakman, T., DeWoody, K. L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70332-x · Cited by 1,080
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A
Flanagan, W. M., Corthésy, B., Bram, R. J., & Crabtree, G. R. (1991) · Nature · doi:10.1038/352803a0 · Cited by 1,056
Treatment of Crohn's Disease with 6-Mercaptopurine: A Long-Term, Randomized, Double-Blind Study
Present, D. H., Korelitz, B. I., Wisch, N., Glass, J. L., Sachar, D. B., & Pasternack, B. S. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021801 · Cited by 1,042
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Dubinsky, M. C., Lamothe, S., Yang, H. Y., Targan, S. R., Sinnett, D., Théorêt, Y., & Seidman, E. G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70140-5 · Cited by 996
Azathioprine and 6-Mercaptopurine in Crohn Disease: A Meta-Analysis
Pearson, D. C., May, G. R., Fick, G. H., & Sutherland, L. R. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-2-199507150-00009 · Cited by 950
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease
Rutgeerts, P., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.014 · Cited by 943
Self-citationEuropean Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
Malchow, H., Ewe, K., Brandes, J. W., Goebell, H., Ehms, H., Sommer, H., & Jesdinsky, H. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90409-8 · Cited by 933
Methotrexate for the Treatment of Crohn's Disease
Feagan, B. G., Rochon, J., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Gillies, R., Hopkins, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320503 · Cited by 911
Colombel, J.-F., Loftus, E. V., Tremaine, W. J., Egan, L. J., Harmsen, W. S., Schleck, C. D., Zinsmeister, A. R., & Sandborn, W. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.047 · Cited by 899
Self-citationDe Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Kandiel, A., Fraser, A. G., Korelitz, B. I., Brensinger, C., & Lewis, J. D. (2005) · Gut · doi:10.1136/gut.2004.049460 · Cited by 808
Gardam, M. A., Keystone, E. C., Menzies, R., Manners, S., Skamene, E., Long, R., & Vinh, D. C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00545-0 · Cited by 752
Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90121-3 · Cited by 743 · cited 1×
“En un estudio que analizó la eficacia de metronidazol (20 mg/kg) durante tres meses después de una resección ileocecal contra placebo, hubo intolerancia al medicamento, lo que limitó su eficacia.(144) El total de recurrencias endoscópicas después de tres meses no se disminuyó significativamente en el grupo con metroni…”
BackgroundA Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 727
Markowitz, J., Grancher, K., Kohn, N., Lesser, M., & Daum, F. (2000) · Gastroenterology · doi:10.1053/gast.2000.18144 · Cited by 716
Clinical, biological, and endoscopic picture of attacks of Crohn's disease
Modigliani, R., Mary, J.-Y., Simon, J.-F., Cortot, A., Soule, J.-C., Gendre, J.-P., & Rene, E. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90002-i · Cited by 699
Frequency of glucocorticoid resistance and dependency in Crohn's disease.
Munkholm, P., Langholz, E., Davidsen, M., & Binder, V (1994) · Gut · doi:10.1136/gut.35.3.360 · Cited by 654
The clinical pharmacology of 6-mercaptopurine
Lennard, L. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02220605 · Cited by 647
Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival
Loftus, E. V., Silverstein, M. D., Sandborn, W. J., Tremaine, W. J., Harmsen, W. S., & Zinsmeister, A. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70421-4 · Cited by 623
Self-citationColombel, J., Ferrari, N., Debuysere, H., Marteau, P., Gendre, J., Bonaz, B., Soulé, J.-C., Modigliani, R., Touze, Y., Catala, P., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70354-4 · Cited by 619
Hanauer, S. B., Wagner, C. L., Bala, M. V., Mayer, L., Travers, S., Diamond, R. H., Olson, A. D., Bao, W., & Rutgeerts, P. J. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00238-1 · Cited by 608
Methotrexate for Rheumatoid Arthritis
Kremer, J. M., Alarcón, G. S., Lightfoot, R. W., Willkens, R. F., Furst, D. E., Williams, H. J., Dent, P. B., & Weinblatt, M. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370304 · Cited by 607
A Comparison of Budesonide with Prednisolone for Active Crohn's Disease
Rutgeerts, P., Lofberg, R., Malchow, H., Lamers, C., Olaison, G., Jewell, D., Danielsson, A., Goebell, H., Thomsen, O. O., Lorenz-Meyer, H., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409293311304 · Cited by 589
Schwartz, D. A., Wiersema, M. J., Dudiak, K. M., Fletcher, J. G., Clain, J. E., Tremaine, W. J., Zinsmeister, A. R., Norton, I. D., Boardman, L. A., Devine, R. M., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28676 · Cited by 575
Self-citationA controlled double blind study of azathioprine in the management of Crohn's disease.
Candy, S., Wright, J., Gerber, M., Adams, G., Gerig, M., & Goodman, R. (1995) · Gut · doi:10.1136/gut.37.5.674 · Cited by 567
Oral Budesonide for Active Crohn's Disease
Greenberg, G. R., Feagan, B. G., Martin, F., Sutherland, L. R., Thomson, A., Williams, C. N., Nilsson, L.-G., & Persson, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409293311303 · Cited by 563
Farrell, R. J., Alsahli, M., Jeen, Y.-T., Falchuk, K. R., Peppercorn, M. A., & Michetti, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50145 · Cited by 550
INTENSIVE INTRAVENOUS REGIMEN FOR SEVERE ATTACKS OF ULCERATIVE COLITIS
Truelove, S. C., & Jewell, D. P. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90552-2 · Cited by 549
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1954) · BMJ · doi:10.1136/bmj.2.4884.375 · Cited by 538
Tumour necrosis factor and Crohn's disease.
Van Deventer, S. J. (1997) · Gut · doi:10.1136/gut.40.4.443 · Cited by 500
Olaison, G., Smedh, K., & Sjodahl, R. (1992) · Gut · doi:10.1136/gut.33.3.331 · Cited by 495
The incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
Dubinsky, M. C., Yang, H., Hassard, P. V., Seidman, E. G., Kam, L. Y., Abreu, M. T., Targan, S. R., & Vasiliauskas, E. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32420 · Cited by 483
Self-citationLong-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
Bouhnik, Y., Scemama, G., Taï, R., Matuchansky, C., Rambaud, J.-C., Lémann, M., Modigliani, R., & Mary, J.-Y. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90402-x · Cited by 466
Hanauer, S. B., Korelitz, B. I., Rutgeerts, P., Peppercorn, M. A., Thisted, R. A., Cohen, R. D., & Present, D. H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.002 · Cited by 460
Self-citationMagnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease
Van Assche, G. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05909-9 · Cited by 457
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.
Hawthorne, A. B., Logan, R. F., Hawkey, C. J., Foster, P. N., Axon, A. T., Swarbrick, E. T., Scott, B. B., & Lennard-Jones, J. E. (1992) · BMJ · doi:10.1136/bmj.305.6844.20 · Cited by 452
Van Assche, G., D’haens, G., Noman, M., Vermeire, S., Hiele, M., Asnong, K., Arts, J., D’hoore, A., Penninckx, F., & Rutgeerts, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01214-9 · Cited by 448
Long-term follow-up of patients with Crohn's disease
Farmer, R. G., Whelan, G., & Fazio, V. W. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90006-x · Cited by 440
Optimizing anti-TNF treatment in inflammatory bowel disease
Rutgeerts, P., van Assche, G., & Vermeire, S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.070 · Cited by 429
The Transfer of Drugs and Other Chemicals Into Human Milk
Committee on Drugs (1994) · Pediatrics · doi:10.1542/peds.93.1.137 · Cited by 426
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
Sands, B. E., Tremaine, W. J., Sandborn, W. J., Rutgeerts, P. J., Hanauer, S. B., Mayer, L., Targan, S. R., & Podolsky, D. K. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00001 · Cited by 422
Self-citationRutgeerts, P., van Assche, G., Vermeire, S., D’Haens, G., Baert, F., Noman, M., Aerden, I., de Hertogh, G., Geboes, K., Hiele, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.010 · Cited by 418
AGA technical review on osteoporosis in gastrointestinal diseases
Bernstein, C. N., Leslie, W. D., & Leboff, M. S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50106 · Cited by 412
D'Haens, G., Lemmens, L., Nevens, F., Hiele, M., Rutgeerts, P., Vandeputte, L., Peeters, M., Vermeire, S., Geboes, K., Van Acker, F., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23983 · Cited by 393
Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine
Black, A. J., McLeod, H. L., Capell, H. A., Powrie, R. H., Matowe, L. K., Pritchard, S. C., Collie-Duguid, E. S. R., & Reid, D. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-9-199811010-00007 · Cited by 374
Brynskov, J., Freund, L., Rasmussen, S. N., Lauritsen, K., Muckadell, O. S. D., Williams, N., MacDonald, A. S., Tanton, R., Molina, F., Campanini, M. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211301 · Cited by 369
Intravenous cyclosporin in ulcerative colitis: a five-year experience
Cohen, R. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00205-1 · Cited by 363
Self-citationSands, B. E., Blank, M. A., Patel, K., & Van Deventer, S. J. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00414-8 · Cited by 359
Probert, C. S. J., Hearing, S. D., Schreiber, S., Kühbacher, T., Ghosh, S., Arnott, I. D. R., & Forbes, A. (2003) · Gut · doi:10.1136/gut.52.7.998 · Cited by 355
Aberra, F. N., Lewis, J. D., Hass, D., Rombeau, J. L., Osborne, B., & Lichtenstein, G. R. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00883-7 · Cited by 350
Self-citationA Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active Proctocolitis
Powell-Tuck, J., Bown, R. L., & Lennard-Jones, J. E. (1978) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527809182199 · Cited by 335
Intensive intravenous treatment of ulcerative colitis
Järnerot, G., Rolny, P., & Sandberg-Gertzén, H. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90201-x · Cited by 333
Sandborn, W. J., Present, D. H., Isaacs, K. L., Wolf, D. C., Greenberg, E., Hanauer, S. B., Feagan, B. G., Mayer, L., Johnson, T., Galanko, J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00877-1 · Cited by 333
DOUBLE-BLIND WITHDRAWAL TRIAL OF AZATHIOPRINE AS MAINTENANCE TREATMENT FOR CROHN'S DISEASE
O'Donoghue, D. P., Dawson, A. M., Powell-Tuck, J., Bown, R. L., & Lennard-Jones, J. E. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92524-2 · Cited by 332
Azathioprine in Ulcerative Colitis: Final Report on Controlled Therapeutic Trial
Jewell, D. P., & Truelove, S. C. (1974) · BMJ · doi:10.1136/bmj.4.5945.627 · Cited by 332
Vermeire, S., Noman, M., Van Assche, G., Baert, F., Van Steen, K., Esters, N., Joossens, S., Bossuyt, X., & Rutgeerts, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00701-7 · Cited by 327
A Comparison of Budesonide and Mesalamine for Active Crohn's Disease
Thomsen, O. Ø., Cortot, A., Jewell, D., Wright, J. P., Winter, T., Veloso, F. T., Vatn, M., Persson, T., & Pettersson, E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390603 · Cited by 327
Oral budesonide is as effective as oral prednisolone in active Crohn’s disease
Campieri, M., Ferguson, A., Doe, W., Persson, T., Nilsson, L.-G., & the Global Budesonide Study Group (1997) · Gut · doi:10.1136/gut.41.2.209 · Cited by 324
Malignancy in Crohn's disease.
Gyde, S. N., Prior, P., Macartney, J. C., Thompson, H., Waterhouse, J. A., & Allan, R. N. (1980) · Gut · doi:10.1136/gut.21.12.1024 · Cited by 323
CONTROLLED TRIAL OF AZATHIOPRINE IN CROHN'S DISEASE
Willoughby, J. M. T., Beckett, J., Kumar, P., & Dawson, A. M. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90268-6 · Cited by 314
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.
Marshall, J. K., & Irvine, E. J. (1997) · Gut · doi:10.1136/gut.40.6.775 · Cited by 314
Ljung, T., Karlén, P., Schmidt, D., Hellström, P. M., Lapidus, A., Janczewska, I., Sjöqvist, U., & Löfberg, R. (2004) · Gut · doi:10.1136/gut.2003.018515 · Cited by 313
Crohn's disease and cancer: A population-based cohort study
Persson, P.-G., Karlén, P., Bernell, O., Leijonmarck, C.-E., Broström, O., Ahlbom, A., & Hellers, G. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90807-9 · Cited by 306
Cuffari, C., Hunt, S., & Bayless, T. M. (2001) · Gut · doi:10.1136/gut.48.5.642 · Cited by 306
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
Ardizzone, S., Maconi, G., Sampietro, G. M., Russo, A., Radice, E., Colombo, E., Imbesi, V., Molteni, M., Danelli, P. G., Taschieri, A. M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.051 · Cited by 297
Oren, R., Arber, N., Odes, S., Moshkowitz, M., Keter, D., Pomeranz, I., Ron, Y., Reisfeld, I., Broide, E., Lavy, A., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613046 · Cited by 297
Inflammatory bowel disease is not associated with an increased risk of lymphoma
Lewis, J. D., Bilker, W. B., Brensinger, C., Deren, J. J., Vaughn, D. J., & Strom, B. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.28703 · Cited by 296
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease
Hellers, G., Cortot, A., Jewell, D., Leijonmarck, C. E., Löfberg, R., Malchow, H., Nilsson, L.-G., Pallone, F., Pena, S., Persson, T., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70125-3 · Cited by 295
Out-patient Treatment of Ulcerative Colitis
Baron, J. H., Connell, A. M., Kanaghinis, T. G., Lennard-Jones, J. E., & Jones, F. A. (1962) · BMJ · doi:10.1136/bmj.2.5302.441 · Cited by 288
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Gonadal Dysfunction in Patients Receiving Chemotherapy for Cancer
SCHILSKY, R. L., LEWIS, B. J., SHERINS, R. J., & YOUNG, R. C. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-1-109 · Cited by 283
Effects of glucocorticoids on gene transcription
Hayashi, R., Wada, H., Ito, K., & Adcock, I. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.011 · Cited by 277
Cohen, R. D., Woseth, D. M., Thisted, R. A., & Hanauer, S. B. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01940.x · Cited by 277
Self-citationImproved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Tetzloff, W., Grevel, J., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018923912135 · Cited by 275
Survival and causes of death in patients with inflammatory bowel disease: A population-based study
Ekbom, A., Helmick, C. G., Zack, M., Holmberg, L., & Adami, H.-O. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90029-x · Cited by 265
National Cooperative Crohn's Disease Study: Adverse reactions to study drugs
Singleton, J. W., Law, D. H., Kelley, M. L., Mekhjian, H. S., & Sturdevant, R. A. L. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90386-x · Cited by 263
Endoscopic monitoring of Crohn's disease treatment: A prospective, randomized clinical trial
Landi, B., Anh, T. N., Cortot, A., Soule, J. C., Rene, E., Gendre, J. P., Bories, P., See, A., Metman, E. H., Florent, C., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91725-j · Cited by 261
Low-Dose Cyclosporine for the Treatment of Crohn's Disease
Feagan, B. G., McDonald, J., Rochon, J., Laupacis, A., Fedorak, R. N., Kinnear, D., Saibil, F., Groll, A., Archambault, A., Gillies, R., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302602 · Cited by 254
Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma
Lewis, J. D., Schwartz, J. S., & Lichtenstein, G. R. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70353-2 · Cited by 242
Self-citationControlled trial of azathioprine in chronic ulcerative colitis.
Kirk, A. P., & Lennard-Jones, J. E. (1982) · BMJ · doi:10.1136/bmj.284.6325.1291 · Cited by 228
Extracolonic malignancies in inflammatory bowel disease
Ekbom, A., Helmick, C., Zack, M., & Adami, H.-O. (1991) · Cancer · doi:10.1002/1097-0142(19910401)67:7<2015::aid-cncr2820670731>3.0.co;2-r · Cited by 226
A Controlled Trial of Azathioprine in the Management of Chronic Ulcerative Colitis
Rosenberg, J. L., Wall, A. J., Levin, B., Binder, H. J., & Kirsner, J. B. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32641-1 · Cited by 224
Szumlanski, C., & Weinshilboum, R. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04478.x · Cited by 223
Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease
Regueiro, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00430-1 · Cited by 221
Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease
Ewe, K., Press, A. G., Singe, C. C., Stufler, M., Ueberschaer, B., Hommel, G., & Büschenfelde, K.-H. M. Z. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90709-l · Cited by 217
Kremer, J. M., Galivan, J., Streckfuss, A., & Kamen, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290703 · Cited by 217
A Critical Review of Cyclosporine Therapy in Inflammatory Bowel Disease
Sandborn, W. J. (1995) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780010107 · Cited by 217
Budesonide versus prednisone in the treatment of active Crohn's disease
Bar–Meir, S., Chowers, Y., Lavy, A., Abramovitch, D., Sternberg, A., Leichtmann, G., Reshef, R., Odes, S., Moshkovitz, M., Bruck, R., et al. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70254-9 · Cited by 211
Löfberg, R., Rutgeerts, P., Malchow, H., Lamers, C., Danielsson, A., Olaison, G., Jewell, D., Ostergaard Thomsen, O., Lorenz-Meyer, H., Goebell, H., et al. (1996) · Gut · doi:10.1136/gut.39.1.82 · Cited by 209
Infliximab in the treatment of Crohn's disease: a user's guide for clinicians
Sandborn, W. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05510-7 · Cited by 203
A controlled trial of azathioprine in Crohn's disease
Rosenberg, J. L., Levin, B., Wall, A. J., & Kirsner, J. B. (1975) · The American Journal of Digestive Diseases · doi:10.1007/bf01070829 · Cited by 201
Neurath, M. F., Wanitschke, R., Peters, M., Krummenauer, F., zum Büschenfelde, K.-H. M., & Schlaak, J. F. (1999) · Gut · doi:10.1136/gut.44.5.625 · Cited by 199
PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION
Lennard-Jones, J. E., Misiewicz, J. J., Connell, A. M., Baron, J. H., & Avery Jones, F. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90973-6 · Cited by 193
Comparison of Corticosteroid and Sulphasalazine Therapy in Ulcerative Colitis
Truelove, S. C., Watkinson, G., & Draper, G. (1962) · BMJ · doi:10.1136/bmj.2.5321.1708 · Cited by 192
Mulder, C. J. J., Fockens, P., Meijer, J. W. R., van der Heide, H., Wiltink, H. H., & Tytgat, G. N. J. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199606000-00010 · Cited by 192
Jess, T., Winther, K. V., Munkholm, P., Langholz, E., & Binder, V. (2002) · Gastroenterology · doi:10.1053/gast.2002.33632 · Cited by 191
Lofberg, R., Danielsson, A., Suhr, O., Nilsson, A., Schioler, R., Nyberg, A., Hultcrantz, R., Kollberg, B., Gillberg, R., Willen, R., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964395 · Cited by 189
Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritis
Murphy, C. C., Ayliffe, W. H., Booth, A., Makanjuola, D., Andrews, P. A., & Jayne, D. (2004) · Ophthalmology · doi:10.1016/s0161-6420(03)00721-8 · Cited by 188
Type II Collagen Gene Variants and Inherited Osteonecrosis of the Femoral Head
Liu, Y.-F., Chen, W.-M., Lin, Y.-F., Yang, R.-C., Lin, M.-W., Li, L.-H., Chang, Y.-H., Jou, Y.-S., Lin, P.-Y., Su, J.-S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042480 · Cited by 185
CONTROLLED TRIAL OF AZATHIOPRINE IN CROHN'S DISEASE
Rhodes, J., Beck, P., Bainton, D., & Campbell, H. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90598-8 · Cited by 184
Egan, L. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00030-6 · Cited by 183
Psoriasis, Methotrexate, and Oligospermia
Sussman, A. (1980) · Archives of Dermatology · doi:10.1001/archderm.116.2.215 · Cited by 179
Mow, W. S., Abreu-martin, M. T., Papadakis, K. A., Pitchon, H. E., Targan, S. R., & Vasiliauskas, E. A. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00060-6 · Cited by 177
Amsterdam, A., Tajima, K., & Sasson, R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01147-4 · Cited by 166
Risk factors for early postoperative recurrence of Crohn's disease
Lautenbach*, E., Berlin‡, J. A., & Lichtenstein§, G. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70191-x · Cited by 164
Self-citationResponse of Refractory Colitis to Intravenous or Oral Tacrolimus (FK506)
Fellermann, K., Tanko, Z., Herrlinger, K. R., Witthoeft, T., Homann, N., Bruening, A., Ludwig, D., & Stange, E. F. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200209000-00002 · Cited by 160
Corticosteroids in Crohn's disease
Yang, Y., & Lichtenstein, G. R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05596.x · Cited by 158
Self-citationSchoon, E. J., Bollani, S., Mills, P. R., Israeli, E., Felsenberg, D., Ljunghall, S., Persson, T., Haptén-White, L., Graffner, H., Bianchi Porro, G., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00662-7 · Cited by 158
Treatment of Crohn's Disease with Azathioprine: A Controlled Evaluation
Klein, M., Binder, H. J., Mitchell, M., Aaronson, R., & Spiro, H. (1974) · Gastroenterology · doi:10.1016/s0016-5085(74)80166-6 · Cited by 158
Winter, J., Walker, A. W., Shapiro, D., Gaffney, D., Spooner, R. J., & Mills, P. R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02124.x · Cited by 157
Olsalazine and 6-mercaptopurine-related bone marrow suppression: A possible drug-drug interaction
Lewis, L. D., Benin, A., Szumlanski, C. L., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90125-9 · Cited by 156
European trial of cyclosporine in chronic active Crohn's disease: A 12-month study
Stange, E. F., Modigliani, R., Peña, A. S., Wood, A. J., Feutren, G., & Smith, P. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90384-4 · Cited by 152
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
Haderslev, K. V., Tjellesen, L., Sørensen, H. A., & Staun, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.16518 · Cited by 150
Kaskas, B., Louis, E., Hindorf, U., Schaeffeler, E., Deflandre, J., Graepler, F., Schmiegelow, K., Gregor, M., Zanger, U. M., Eichelbaum, M., et al. (2002) · Gut · doi:10.1136/gut.52.1.140 · Cited by 150
Modigliani, R., Colombel, J. F., Jl, D., Dapoigny, M. C., Costil, V., Veyrac, M., Duclos, B., Soulé, J. C., Jp, G., Jp, G., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608877 · Cited by 149
Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours.
Rustin, G. J. S., Booth, M., Dent, J., Salt, S., Rustin, F., & Bagshawe, K. D. (1984) · BMJ · doi:10.1136/bmj.288.6411.103 · Cited by 149
van Bodegraven, A. A., Sloots, C. E. J., Felt-Bersma, R. J. F., et al. (2002) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6111-6 · Cited by 146
Lowry, P. W., Weaver, A. L., Tremaine, W. J., et al. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199911000-00001 · Cited by 142
Self-citationSandborn, W. J., Tremaine, W. J., Schroeder, K. W., Batts, K. P., Lawson, G. M., Steiner, B. L., Harrison, J. M., & ZINSMEISTER, A. R. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90394-8 · Cited by 135
Self-citationDanielsson, Å., Hellers, G., Lyrenäs, E., Löfberg, R., Nilsson, A. M., Olsson, O., Olsson, S., Persson, T., Salde, L., Næsdal, J., et al. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528708991947 · Cited by 132
Intravenous cyclosporine in attacks of ulcerative colitis
Carbonnel, F., Boruchowicz, A., Duclos, B., Soulé, J. C., Lerebours, É., Lémann, M., Bélaïche, J., Colombel, J., Cosnes, J., & Gendre, J. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02100145 · Cited by 131
Buttgereit, F., Saag, K. G., Cutolo, M., da Silva, J. A. P., & Bijlsma, J. W. J. (2005) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740510017706 · Cited by 127
Remicade® Does Not Abolish the Need for Surgery in Fistulizing Crohn's Disease
Poritz, L. S., Rowe, W. A., & Koltun, W. A. (2002) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6296-8 · Cited by 126
Oral budesonide as maintenance therapy in Crohn’s disease—results of a 12‐month study
Ferguson, Campieri, M., Doe, Persson, Nygård, & THE GLOBAL BUDESONIDE STUDY GROUP (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00285.x · Cited by 124
Tremaine, W. J., Hanauer, S. B., Katz, S., Winston, B., Levine, J. G., Persson, T., & Persson, A. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05835.x · Cited by 121
Self-citationSandborn, W. J., Löfberg, R., Feagan, B. G., Hanauer, S. B., Campieri, M., & Greenberg, G. R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41992.x · Cited by 119
Demyelination During Anti-Tumor Necrosis Factor α Therapy With Infliximab for Crohn's Disease
Thomas, C. W., Weinshenker, B. G., & Sandborn, W. J. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200401000-00004 · Cited by 118
The evolving role of liver biopsy
Campbell, M. S., & Reddy, K. R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02071.x · Cited by 118
Tao, Y., Williams-Skipp, C., & Scheinman, R. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000526200 · Cited by 117
Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways
Clark, A. R., & Lasa, M. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00073-0 · Cited by 116
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
Kane, S. V., Schoenfeld, P., Sandborn, W. J., Tremaine, W. J., Hofer, T. P., & Feagan, B. G. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01289.x · Cited by 116
Self-citationThe effect of infliximab on extraintestinal manifestations of Crohn’s disease
Kaufman, I., Caspi, D., Yeshurun, D., Dotan, I., Yaron, M., & Elkayam, O. (2004) · Rheumatology International · doi:10.1007/s00296-004-0467-8 · Cited by 113
Schütz, E., Svinarov, D. A., Shipkova, M., Niedmann, P.-D., Armstrong, V. W., Wieland, E., & Oellerich, M. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.10.2158 · Cited by 111
Edsbäcker, S., Bengtsson, B., Larsson, P., Lundin, P., Nilsson, Å., Ulmius, J., & Wollmer, P. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01426.x · Cited by 111
Herfarth, H. H., Obermeier, F., Andus, T., Rogler, G., Nikolaus, S., Kuehbacher, T., & Schreiber, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06064.x · Cited by 110
Effect of oral tacrolimus (FK 506) on steroid‐refractory moderate/severe ulcerative colitis
Högenauer, C., Wenzl, H., Hinterleitner, T. A., & Petritsch, W. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01662.x · Cited by 110
Cortot, A., Colombel, J.-F., Rutgeerts, P., Lauritsen, K., Malchow, H., Hämling, J., Winter, T. A., Gossum, A. V., Persson, T., & Pettersson, E. (2001) · Gut · doi:10.1136/gut.48.2.186 · Cited by 110
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.
Clements, D. S., Compston, J., Evans, W. D., & Rhodes, J. (1993) · Gut · doi:10.1136/gut.34.11.1543 · Cited by 107
Gross, V., Andus, T., Ecker, K. W., Raedler, A., Loeschke, K., Plauth, M., Rasenack, J. W. F., Weber, A., Gierend, M., Ewe, K., et al. (1998) · Gut · doi:10.1136/gut.42.4.493 · Cited by 107
Spencer, C. M., & McTavish, D. (1995) · Drugs · doi:10.2165/00003495-199550050-00006 · Cited by 104
Budesonide versus prednisolone retention enemas in active distal ulcerative colitis
Löfberg, R., Thomsen, O. Ø., Langholz, E., Schiöler, R., Danielsson, Å., Suhr, O. B., Graffner, H., Påhlman, L., Matzen, P., Møller-Petersen, J., et al. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00340.x · Cited by 103
Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab)
Benitez-del-Castillo, J. M., Martínez-de-la-Casa, J. M., Pato-Cour, E., Méndez-Fernández, R., Lopez-Abad, C., Matilla, M. T., & Garcia-Sanchez, J. (2004) · Eye · doi:10.1038/sj.eye.6701689 · Cited by 103
The molecular complexity of glucocorticoid actions in inflammation — a four-ring circus
Goulding, N. J. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.06.009 · Cited by 98
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease
Fellermann, Steffen, Stein, J. M., et al. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00695.x · Cited by 95
Infliximab in the surgical management of complex fistulating anal Crohn's disease
Talbot, C., Sagar, P. M., Johnston, M. J., Finan, P. J., & Burke, D. (2005) · Colorectal Disease · doi:10.1111/j.1463-1318.2004.00749.x · Cited by 95
Dermatologic Manifestations of Crohn Disease in Children: Response to Infliximab
Kugathasan, S., Miranda, A., Nocton, J. J., Drolet, B. A., Raasch, C., & Binion, D. G. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200308000-00013 · Cited by 89
Domènech, E., García-Planella, E., Bernal, I., Rosinach, M., Cabré, E., Fluvià, L., Boix, J., & Gassull, M. À. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01385.x · Cited by 87
Oral cyclosporin for chronic active Crohnʼs disease
Jewell, D. P., & Lennard-Jones, J. E. (1994) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199406000-00009 · Cited by 87
CYCLOSPORIN IN ULCERATIVE COLITIS
Gupta, S., Keshavarzian, A., & Hodgson, H. J. F. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92826-5 · Cited by 87
Brynskov, J., Freund, L. G., Rasmussen, S. N., Lauritsen, K., de Muckadell, O. B. S., Williams, C. N., MacDonald, A. S., Tanton, R., Molina, F., Campanini, M., et al. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529108998585 · Cited by 86
Preventing antibodies to infliximab in patients with Crohn's disease: Optimize not immunize
Sandborn, W. J. (2003) · Gastroenterology · doi:10.1053/gast.2003.50182 · Cited by 85
Matzen, P. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529108998618 · Cited by 84
A Lupus-like Syndrome Associated With Infliximab Therapy
Klapman, J. B., Ene‐Stroescu, D., Becker, M. A., & Hanauer, S. B. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200305000-00005 · Cited by 82
Cyclosporin a Retention Enemas in Refractory Distal Ulcerative Colitis and ‘Pouchitis’
Winter, T. A., Dalton, H. R., Merrett, M. N., Campbell, A., & Jewell, D. P. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098276 · Cited by 81
Enhancement of the oral absorption of cyclosporin in man.
Drewe, J., Meier, R. F., Vonderscher, J., Kiss, D., Posanski, U., Kissel, T., & Gyr, K. E. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04108.x · Cited by 80
Budesonide as maintenance treatment in Crohn's disease: a placebo‐controlled trial
Hanauer, S. B., Sandborn, W. J., Persson, A., & Persson, T. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02338.x · Cited by 80
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study
Temekonidis, T. I., Alamanos, Y., Nikas, S. N., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014258 · Cited by 73
Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease
Sandborn, W. J., & Loftus, E. V. (2004) · Gut · doi:10.1136/gut.2003.020552 · Cited by 71
Review article: monitoring of immunomodulators in inflammatory bowel disease
Aberra, F. N., & Lichtenstein, G. R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02343.x · Cited by 68
Self-citationListeria Meningitis Associated with Infliximab
Bowie, V. L., Snella, K. A., Gopalachar, A. S., & Bharadwaj, P. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d151 · Cited by 67
Miehsler, W., Reinisch, W., Moser, G., Gangl, A., & Vogelsang, H. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03622.x · Cited by 66
Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine
Su, C. G., & Lichtenstein, G. R. (2004) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2004.02.004 · Cited by 63
Self-citationGlucocorticoid suppression of nuclear factor-κB: a role for histone modifications
Kagoshima, M., Ito, K., Cosío, B. G., et al. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310060 · Cited by 60
Infliximab-Associated Retrobulbar Optic Neuritis
Mejico, L. J. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.5.793 · Cited by 59
Use of an Intravenous Steroid Regimen in the Treatment of Acute Crohn???s Disease
Shepherd, H. A., Barr, G. D., & Jewell, D. P. (1986) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198604000-00010 · Cited by 55
Medical Therapy To Reduce Postoperative Crohn's Disease Recurrence
Achkar, J.-P., & Hanauer, S. B. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00792-9 · Cited by 54
Sandborn, W. J., & Feagan, B. G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.037 · Cited by 54
Lundin, P., Edsbäcker, S., Bergstrand, M., Ejderhamn, J., Linander, H., Högberg, L., Persson, T., Escher, J. C., & Lindquist, B. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01386.x · Cited by 52
Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitis
Porro, G. B., Prantera, C., Campieri, M., Petrillo, M., Campanini, M. C., Gionchetti, P., Grandinetti, G., Mangiarotti, R., Brunetti, G., & Ranzi, T. (1994) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199402000-00007 · Cited by 51
Absorption of prednisolone in patients with Crohn's disease.
Shaffer, J. L., Williams, S. E. I., Turnberg, L. A., Houston, J. B., & Rowland, M. (1983) · Gut · doi:10.1136/gut.24.3.182 · Cited by 50
Oral Tacrolimus (FK 506) in Crohn's Disease Complicated by Fistulae of the Perineum
Ierardi, E., Principi, M., Rendina, M. G., et al. (2000) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200003000-00015 · Cited by 48
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.019 · Cited by 42
Use of laboratory testing to guide 6-mercaptopurine/azathioprine therapy
Lichtenstein, G. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.061 · Cited by 38
Self-citationInfluence of steroid treatment's duration in patients with active Crohn's disease
Brignola, C., SIMONE, G. D., Iannone, P., Belloli, C., Evangelisti, A., Campieri, M., Belluzzi, A., Gionchetti, P., Tampieri, M., Bertinelli, E., et al. (1992) · Inflammation Research · doi:10.1007/bf01991034 · Cited by 17
Miller‐Larsson, A., Gustafsson, B., PERSSON, C. G. A., & Brattsand, R. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01129.x · Cited by 14
Kornbluth, A. A., & Sachar, D. B. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40036.x · Cited by 5
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Self-citation
Metadata
- Authors
- Lichtenstein, G. R., Abreu, M. T., Cohen, R., & Tremaine, W.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 130
- Issue
- 3
- Pages
- 940-987
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2074509533
- Cited by
- 417
- References
- 200
- FWCI
- 20.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.